These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 27412013)

  • 21. PI3K-Akt-mTOR inhibition by GNE-477 inhibits renal cell carcinoma cell growth
    Ye X; Ruan JW; Huang H; Huang WP; Zhang Y; Zhang F
    Aging (Albany NY); 2020 May; 12(10):9489-9499. PubMed ID: 32421688
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypoxia inducible factor 2α/insulin-like growth factor receptor signal loop supports the proliferation and Oct-4 maintenance of mouse germline stem cells.
    Huang YH; Lin MH; Wang PC; Wu YC; Chiang HL; Wang YL; Chang JH; Huang YK; Gu SY; Ho HN; Ling TY
    Mol Hum Reprod; 2014 Jun; 20(6):526-37. PubMed ID: 24598112
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Morphoproteomics and biomedical analytics confirm the mTORC2/Akt pathway as a resistance signature and activated ERK and STAT3 as concomitant prosurvival/antiapoptotic pathways in metastatic renal cell carcinoma (RCC) progressing on rapalogs: pathogenesis and therapeutic options.
    Brown RE; Buryanek J; Tammisetti VS; McGuire MF; Csencsits-Smith K
    Oncotarget; 2016 Jul; 7(27):41612-41621. PubMed ID: 27223432
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Upregulation of MARCKS in kidney cancer and its potential as a therapeutic target.
    Chen CH; Fong LWR; Yu E; Wu R; Trott JF; Weiss RH
    Oncogene; 2017 Jun; 36(25):3588-3598. PubMed ID: 28166200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of DNA-PKcs as a primary resistance factor of salinomycin in osteosarcoma cells.
    Zhen YF; Li ST; Zhu YR; Wang XD; Zhou XZ; Zhu LQ
    Oncotarget; 2016 Nov; 7(48):79417-79427. PubMed ID: 27765904
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SCP phosphatases suppress renal cell carcinoma by stabilizing PML and inhibiting mTOR/HIF signaling.
    Lin YC; Lu LT; Chen HY; Duan X; Lin X; Feng XH; Tang MJ; Chen RH
    Cancer Res; 2014 Dec; 74(23):6935-46. PubMed ID: 25293974
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Infiltrating macrophages increase RCC epithelial mesenchymal transition (EMT) and stem cell-like populations via AKT and mTOR signaling.
    Yang Z; Xie H; He D; Li L
    Oncotarget; 2016 Jul; 7(28):44478-44491. PubMed ID: 27283897
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TCF21 inhibits proliferation and chemoresistance through the AKT pathway in human gastric cancer.
    Yang Z; Jiang X; Li D; Dong Q; Zhao H; Jiang X
    Gene; 2019 Jan; 682():42-49. PubMed ID: 30296564
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function.
    Krieg M; Haas R; Brauch H; Acker T; Flamme I; Plate KH
    Oncogene; 2000 Nov; 19(48):5435-43. PubMed ID: 11114720
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Everolimus resistance in clear cell renal cell carcinoma: miRNA-101 and HIF-2α as molecular triggers?
    Nogueira I; Dias F; Morais M; Teixeira AL; Medeiros R
    Future Oncol; 2019 Jul; 15(20):2361-2370. PubMed ID: 31267758
    [No Abstract]   [Full Text] [Related]  

  • 31. Dual inhibition of the PI3K/AKT/mTOR pathway suppresses the growth of leiomyosarcomas but leads to ERK activation through mTORC2: biological and clinical implications.
    Fourneaux B; Chaire V; Lucchesi C; Karanian M; Pineau R; Laroche-Clary A; Italiano A
    Oncotarget; 2017 Jan; 8(5):7878-7890. PubMed ID: 28002802
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypoxia-inducible factor (HIF)-independent expression mechanism and novel function of HIF prolyl hydroxylase-3 in renal cell carcinoma.
    Tanaka T; Torigoe T; Hirohashi Y; Sato E; Honma I; Kitamura H; Masumori N; Tsukamoto T; Sato N
    J Cancer Res Clin Oncol; 2014 Mar; 140(3):503-13. PubMed ID: 24477694
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High prevalence of mTOR complex activity can be targeted using Torin2 in papillary thyroid carcinoma.
    Ahmed M; Hussain AR; Bavi P; Ahmed SO; Al Sobhi SS; Al-Dayel F; Uddin S; Al-Kuraya KS
    Carcinogenesis; 2014 Jul; 35(7):1564-72. PubMed ID: 24583924
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of autophagy enhances apoptosis induced by the PI3K/AKT/mTor inhibitor NVP-BEZ235 in renal cell carcinoma cells.
    Li H; Jin X; Zhang Z; Xing Y; Kong X
    Cell Biochem Funct; 2013 Jul; 31(5):427-33. PubMed ID: 23086777
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NKAP promotes renal cell carcinoma growth via AKT/mTOR signalling pathway.
    Ma Q; Hou L; Gao X; Yan K
    Cell Biochem Funct; 2020 Jul; 38(5):574-581. PubMed ID: 32032976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. microRNA-302c-3p inhibits renal cell carcinoma cell proliferation by targeting Grb2-associated binding 2 (Gab2).
    Gu DH; Mao JH; Pan XD; Zhu H; Chen X; Zheng B; Shan Y
    Oncotarget; 2017 Apr; 8(16):26334-26343. PubMed ID: 28412750
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of autophagy in chemoresistance: regulation of the ATM-mediated DNA-damage signaling pathway through activation of DNA-PKcs and PARP-1.
    Yoon JH; Ahn SG; Lee BH; Jung SH; Oh SH
    Biochem Pharmacol; 2012 Mar; 83(6):747-57. PubMed ID: 22226932
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PI3K/Akt promotes feedforward mTORC2 activation through IKKα.
    Dan HC; Antonia RJ; Baldwin AS
    Oncotarget; 2016 Apr; 7(16):21064-75. PubMed ID: 27027448
    [TBL] [Abstract][Full Text] [Related]  

  • 39. miR‑205 suppresses cell proliferation, invasion, and metastasis via regulation of the PTEN/AKT pathway in renal cell carcinoma.
    Wang H; Chen B; Duan B; Zheng J; Wu X
    Mol Med Rep; 2016 Oct; 14(4):3343-9. PubMed ID: 27498834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TNF-α induces epithelial-mesenchymal transition of renal cell carcinoma cells via a GSK3β-dependent mechanism.
    Ho MY; Tang SJ; Chuang MJ; Cha TL; Li JY; Sun GH; Sun KH
    Mol Cancer Res; 2012 Aug; 10(8):1109-19. PubMed ID: 22707636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.